Prevalence of chronic diseases among bus drivers in Hefei， Anhui / 上海预防医学

ObjectiveTo analyze the effect of working conditions on the occurrence and development of chronic diseases in bus drivers in Hefei. MethodsA total of 380 bus drivers were selected by convenient sampling method. Their basic information， working intensity， working environment， working habits， living habits and physical health were investigated. ResultsThe three most common occupational-related diseases were： 1） anxiety and depression caused by work environment such as noise and traffic jam （70.79%， 269/380）； 2） dry eyes， eye fatigue， blurred vision and so on （65.53%， 249/380）； 3） cervical and lumbar pain （63.16%， 240/380）. Gastrointestinal dysfunction （irritable bowel syndrome related symptoms） occurred in 42.37% （161/380） of the drivers and 45.53% （173/380） had suffered from hemorrhoids or anal fissure. Drivers with long-term suffocation were more likely to suffer from urinary tract infection （χ 2=22.330， P<0.001）. The rate of subjective eye discomfort was higher in the drivers with long working hours （χ 2=11.682， P<0.01）， and the rate of leg swelling was higher in the drivers with frequent driving without rest （χ 2=16.642， P<0.05）. There was a significant difference in the rate of anxiety and depression between the divers with different sleep duration （χ 2=17.379，P<0.001）. Results of multiple logistic regression analysis showed that the incidence of anxiety and depression was higher in drivers with longer working hours. In comparison with the group of over 6 working hours， the rate increased to 4.080 times in the group of over 8 working hours， 2.583 times in the group of over 10 working hours， and 2.484 times in the group of over 12 working hours， respectively. Occasional and frequent non-stop working drivers were 4.302 and 4.828 times， respectively， more likely to be anxious or depressed. Logistic regression analysis also showed that the incidence of gastrointestinal dysfunction （irritable bowel syndrome related symptoms） in drivers with anxiety and depression was 3.792 times higher than that in drivers without anxiety and depression （OR=3.792， 95% CI 2.384 to 6.029， P<0.001）. ConclusionSome working environment， excessive working intensity， poor living and working habits， and mental problems are closely related to the occurrence and development of chronic diseases in bus drivers.

Prevalence of chronic diseases among bus drivers in Hefei， Anhui / 上海预防医学

ObjectiveTo analyze the effect of working conditions on the occurrence and development of chronic diseases in bus drivers in Hefei. MethodsA total of 380 bus drivers were selected by convenient sampling method. Their basic information， working intensity， working environment， working habits， living habits and physical health were investigated. ResultsThe three most common occupational-related diseases were： 1） anxiety and depression caused by work environment such as noise and traffic jam （70.79%， 269/380）； 2） dry eyes， eye fatigue， blurred vision and so on （65.53%， 249/380）； 3） cervical and lumbar pain （63.16%， 240/380）. Gastrointestinal dysfunction （irritable bowel syndrome related symptoms） occurred in 42.37% （161/380） of the drivers and 45.53% （173/380） had suffered from hemorrhoids or anal fissure. Drivers with long-term suffocation were more likely to suffer from urinary tract infection （χ 2=22.330， P<0.001）. The rate of subjective eye discomfort was higher in the drivers with long working hours （χ 2=11.682， P<0.01）， and the rate of leg swelling was higher in the drivers with frequent driving without rest （χ 2=16.642， P<0.05）. There was a significant difference in the rate of anxiety and depression between the divers with different sleep duration （χ 2=17.379，P<0.001）. Results of multiple logistic regression analysis showed that the incidence of anxiety and depression was higher in drivers with longer working hours. In comparison with the group of over 6 working hours， the rate increased to 4.080 times in the group of over 8 working hours， 2.583 times in the group of over 10 working hours， and 2.484 times in the group of over 12 working hours， respectively. Occasional and frequent non-stop working drivers were 4.302 and 4.828 times， respectively， more likely to be anxious or depressed. Logistic regression analysis also showed that the incidence of gastrointestinal dysfunction （irritable bowel syndrome related symptoms） in drivers with anxiety and depression was 3.792 times higher than that in drivers without anxiety and depression （OR=3.792， 95% CI 2.384 to 6.029， P<0.001）. ConclusionSome working environment， excessive working intensity， poor living and working habits， and mental problems are closely related to the occurrence and development of chronic diseases in bus drivers.

ADAM10 overexpression confers resistance to doxorubicin-induced apoptosis in hepatocellular carcinoma.

Chemoresistance represents a major obstacle to successful treatment of hepatocellular carcinoma (HCC). A disintegrin and metalloproteinase 10 (ADAM10) is known to be frequently upregulated in many cancers. We aimed to determine the biological function of ADAM10 in the chemoresistance of HCC cells. Overexpression of ADAM10 in three HCC cell lines (HepG2, Hep3B, and Huh7) conferred protection against doxorubicin-induced apoptosis, as determined by Annexin V staining. Western blot analysis revealed that ADAM10-overexpressing cells had a significantly lower amount of cleaved caspase-3 and an elevated expression of myeloid cell leukemia-1 (Mcl-1), a prosurvival member of the Bcl-2 family. Conversely, RNA interference-mediated silencing of endogenous ADAM10 potentiated doxorubicin-induced apoptosis in HepG2 and Hep3B cells, which was coupled with increased cleavage of caspase-3 and decreased expression of Mcl-1. Ectopic expression of ADAM10 resulted in a marked increase in the phosphorylation of phosphatidylinositol 3-kinase (PI3-K) and Akt. Most interestingly, the pretreatment with the PI3-K inhibitor LY294002 significantly enhanced doxorubicin-induced apoptosis and diminished the Mcl-1 expression in ADAM10-overexpressing Huh7 cells. Our data provide evidence that ADAM10 plays an important role in modulating the chemosensitivity of HCC cells, which, at least partially, involves the activation of the PI3-K/Akt pathway. ADAM10 may be a promising target for the improvement of chemotherapeutic efficacy in HCC.

Efficient growth inhibition of ErbB2-overexpressing tumor cells by anti-ErbB2 ScFv-Fc-IL-2 fusion protein in vitro and in vivo.

AIM: To investigate the antitumor activities of an anti-ErbB2 scFv-Fc-interleukin 2 (IL-2) fusion protein (HFI) in vitro and in vivo. METHODS: Fusion protein HFI was constructed. The efficacy of HFI in mediating tumor cell lysis was determined by colorimetric lactate dehydrogenase release assays. The antitumor activity of HFI was evaluated in tumor xenograft models. RESULTS: The fusion protein was folded as a homodimer formed by covalently linking Fc portions and it retained ErbB2 specificity and IL-2 biological activity. HFI mediated antibody-dependent cell-mediated cytotoxicity (ADCC) at low effector-to-target ratios in vitro and improved the therapeutic efficacy of IL-2 in experiments in vivo. CONCLUSION: The genetically-engineered anti-ErbB2 scFv-Fc-IL-2 fusion protein exhibited high efficiency both in mediating ADCC in vitro and significant antitumor activity in tumor xenograft models.

Immune tolerance in pancreatic islet xenotransplantation.

AIM: To observe the effect of tail vein injection with donor hepatocytes and/or splenocytes on the islet xenotransplantation rejection. METHODS: New-born male pigs and BALB/C mice were selected as donors and recipients respectively. Islet xenotransplantation was performed in recipients just after the third time of tail vein injection with donor hepatocytes and/or splenocytes. Macrophage phagocytosis, NK(natural killing cell) killing activity, T lymphocyte transforming function of spleen cells, antibody forming function of B lymphocytes, and T lymphocyte subsets were taken to monitor transplantation rejection. The effects of this kind of transplantation were indicated as variation of blood glucose and survival days of recipients. RESULTS: The results showed that streptozotocin (STZ) could induce diabetes mellitus models of mice. The pre-injection of donor hepatocytes, splenocytes or their mixture by tail vein injection was effective in preventing donor islet transplantation from rejection, which was demonstrated by the above-mentioned immunological marks. Each group of transplantation could decrease blood glucose in recipients and increase survival days. Pre-injection of mixture of donor hepatocytes and splenocytes was more effective in preventing rejection as compared with that of donor hepatocyte or splenocyte pre-injection respectively. CONCLUSION: Pre-injection of donor hepatocytes, splenocytes or their mixture before donor islet transplantation is a good way in preventing rejection.

The role of donor hepatocytes and/or splenocytes pre-injection in reducing islet xenotransplantation rejection.

OBJECTIVE: To observe the effect of tail vein injection with donor hepatocyte and/or splenocyte on islets xenotransplantation rejection. METHODS: New-born male pigs and BALB/C mice were selected as donors and recipients respectively. Islets xenotransplantation was performed in recipients just after the third time of tail vein injection with donor hepatocytes and/or splenocytes. Macrophage phagocytosis, NK killing activity, T lymphocyte transforming function of spleen cells, antibody forming function of B lymphocytes, and T lymphocyte subsets were taken to monitor transplantation rejection. The effects of this kind of transplantation were indicated as variation of blood glucose and survival days of recipients. RESULTS: Streptozotocin (STZ) succeeded in inducing diabetes mellitus models of mice. Pre-injection of donor hepatocytes, and splenocytes or their mixture via tail vein was effective in preventing donor islets transplantation from rejection, which was demonstrated by the mentioned immunological marks. And each group of transplantation could decrease the blood glucose of recipients and prolong the survival days. Pre-injection of mixture of donor hepatocytes and splenocytes was more effective in preventing rejection than pre-injection of donor hepatocytes or splenocytes separately. CONCLUSION: We propose that pre-injection of donor hepatocytes, splenocytes separately or their mixture before donor islets transplantation is a good way to prevent rejection.